JEFYTRAN

This brand name is authorized in Nigeria.

Active ingredients

The drug JEFYTRAN contains a combination of these active pharmaceutical ingredients (APIs):

1	Ceftriaxone UNII 023Z5BR09K - CEFTRIAXONE SODIUM
	Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death.
	Read more about Ceftriaxone
2	Sulbactam UNII DKQ4T82YE6 - SULBACTAM SODIUM
	Read more about Sulbactam

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7955	Powder for injection	JEFYTRAN-SL 1.5GM POWDER FOR INJECTION INJ_PWD 1000 mg; 500 mg 1 VIAL+1 AMPOULE OF WFI	34 CMS-PP-405622 JEFYTRAN-SL 1.5GM POWDER FOR INJECTION (CEFTRIAXONE SODIUM USP (STERILE) 1000MG, SULBACTAM SODIUM USP (STERILE) 500MG) Ceftriaxone Sodium USP (Sterile) 1000mg, Sulbactam Sodium USP (Sterile) 500mg B4-7955 Drugs Imported Products 1 VIAL+1 AMPOULE OF WFI Prescription Only Medicine (POM) SJS LIFE SCIENCES LIMITED, 11, OLU AKERELE STREET IKEJA LAGOS 8114441430 sjslifesciencesltd@gmail.com SHAMSHREE LIFESCIENCES LIMITED, Plot No. 11, Industrial Area, Katha-Bhatolikalan,Baddi – 173205 (H.P.), India, India	30/04/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD63		J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD63

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7955